Relapsed/Refractory Multiple Myeloma Webinar – West Coast
This high-impact, 90-minute educational program will focus on the latest evidence for optimizing treatments for RRMM patients including treating early relapse and late relapse with high risk patients. Key concepts will be covered in presentations by senior faculty, along with practice-relevant case-based discussions.
Program
Our sponsors:
Practical Insights in and Translational Aspects of Novel Immune Therapies in Multiple Myeloma 2025
Are you a hematologist or oncologist treating patients with multiple myeloma?
If so, this workshop is for you!
This high-impact educational program, held in conjunction with the DGHO Annual Meeting, seeks to bridge the knowledge gap between CAR T administering centers and smaller community centers where the vast majority of oncology patients are treated, and raise awareness of novel immune based strategies including antibody drug conjugates, bispecific T cell engages, and CAR T therapies among healthcare professionals.
Preliminary Agenda
Our sponsors:
Platinum
Gold
Educational Workshop in Belgrade, Serbia
Join us for a dynamic educational workshop on the diagnosis, treatment, and monitoring of plasma cell malignancies, including current practices and opportunities for improvement. This workshop will include lectures plus roundtable discussions around hot and controversial topics, featuring point-counterpoint conversations between invited speakers and local hematologists based on both challenging questions and clinical cases.
Preliminary Program
7th Immune Effector Cell Therapies in Multiple Myeloma Workshop
IMS is pleased to announce that the 7th Annual Immune Effector Cell will take place from March 27-28, 2026 in Boston, MA.
Our sponsors:
Titanium
4th Annual Workshop on Genomics
IMS is pleased to announce that the 4th Annual Workshop on Genomics will take place from July 10-11, 2026 in Warsaw, Poland.
More details will be available soon!
Why Become a Member
The International Myeloma Society is a professional, scientific, and medical society established to bring together clinical and experimental scientists involved in the study of myeloma. The purpose of this society is to promote research, education, clinical studies (including diagnosis and treatment), workshops, conferences, and symposia on all aspects of multiple myeloma worldwide.
The IMS is a membership organization comprised of basic research scientists, and clinical investigators in the field along with physicians and other healthcare practitioners.
